- Juniorstocks.com
- Posts
- Access Granted, Downward Dog Disaster and Egos Collide: Weekly Recap
Access Granted, Downward Dog Disaster and Egos Collide: Weekly Recap
You're receiving this newsletter as a subscriber to JuniorStocks.com. Join the conversation on our socials below.
Featured Article this week:
Historic Asset Reopened: Military Metals secured an Access Agreement at Nova Scotia’s West Gore site—once Canada’s top antimony producer during WWI—to launch modern exploration, including drone surveys and drilling.
Critical Mineral Upside: The site hosts high-grade antimony and gold in quartz fissure veins, with mineralogical complexity and open zones at depth—offering strong potential for new discoveries in a tight global antimony market.
Strategic Timing: With rising demand for antimony in defense, semiconductors, and energy storage—and 80% of supply from China/Russia—Military Metals is advancing a domestic supply source aligned with Canadian and U.S. critical mineral priorities.
Lululemon Stumbles Hard — Wall Street Says “Buy”
Shares plunged nearly 20% after weak guidance overshadowed a solid Q1 beat. Analysts slashed price targets but remain bullish on long-term growth, especially in China.
Outlook Sinks the Stock: LULU shares plunged -19.9% to $264.88 after the company cut full-year EPS guidance by 2.5% to $14.58–$14.78 and issued soft Q2 guidance ($2.85–$2.90 vs. $3.28 est.), citing 110bps in gross margin compression tied to tariffs and markdown pressure.
Analysts Remain Cautiously Bullish: JPMorgan, BofA, Truist, and Needham all maintained Buy/Overweight ratings but slashed price targets across the board:
JPM: $389 → $303
BofA: $400 → $370
Needham: $366 → $317
Truist: $297 → $290
Concerns include sluggish U.S. sales, slowing international comps, and China growth deceleration, though management still expects +25%–30% YoY growth in China.
BREAKING 🚨: Lululemon
Death Candle for $LULU - Obliterated
— Barchart (@Barchart)
10:21 PM • Jun 5, 2025
Q1 Results Beat — But Ignored: LULU posted Q1 EPS of $2.60 (above guidance and consensus), with 7.3% YoY revenue growth and improving margins. However, macro headwinds and muted foot traffic overshadowed these results, triggering a sharp selloff.
Market Snapshot This Week:
Tech Rallies on AI Optimism:
Nvidia (NVDA +5.17%), Micron (MU +15.80%), and other semiconductors surged following a strong AI demand outlook and Micron’s bullish earnings driven by high-bandwidth memory chips for AI servers.
Microsoft (+2.27%) and Oracle (+4.77%) also rallied on enterprise AI deployment updates.
Meta (+7.36%) jumped after announcing broader monetization of its AI tools and infrastructure.
Tesla Drags Consumer Cyclical Sector:
Tesla (TSLA -13.43%) tanked after reports of slowing global EV deliveries, price cuts in China, and CEO Elon Musk’s comments hinting at delays in next-gen vehicle production.
Broader consumer cyclical names like Nike (+2.85%) and Amazon (+3.68%) rose on resilient U.S. spending and AI-driven logistics gains at AMZN.
Healthcare & Financials Mixed on Guidance and Rates:
Eli Lilly (+4.00%) rallied on positive obesity drug trial results.
Berkshire Hathaway (BRK-B -2.26%) fell as investors rotated out of defensive holdings and priced in lower future insurance margins.
CME Group (-5.16%) declined sharply after missing revenue forecasts and issuing soft guidance tied to reduced futures volume expectations.

All data current as of 2pm EST 06/06/2025
Top Viewed Articles this week:
We want your feedback on this week’s market insights! How’d we perform? 📈📉Let us know where we stand! 🚀 |